Tag: opioids market demand

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Opioids Market Forecast: Value Set To Climb From $24.62 Billion To $28.59 Billion

The opioids market has experienced consistent expansion in its size over recent years. Its valuation is projected to rise from $23.98 billion in 2025 to $24.63 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 2.7%. Historically, this growth can be attributed to the prevalence of post-surgical pain, rising cancer incidence, widespread opioid prescription practices, limited availability of alternative pain therapies, and strong hospital-based opioid usage.

The opioids market size is projected to experience consistent expansion over the upcoming years, with expectations to reach $28.59 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 3.8%. This anticipated growth can be ascribed to several factors, including an increase in the chronic pain population, the development of safer opioid formulations, the expansion of palliative care services, greater regulatory clarity for controlled substances, and the rising demand for effective pain management among aging populations. Significant trends foreseen during this period involve the advancement of precision-guided opioid therapy, the integration of digital prescription monitoring, a shift towards abuse-deterrent formulations, the expansion of long-acting and extended-release opioids, and the growing application of opioids in oncology pain management.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=29760215&type=smp&name=Opioids%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Opioids Market Growth Drivers: What’s Behind The Acceleration?

The expanding presence of chronic ailments is anticipated to fuel the expansion of the opioids market in the future. Chronic illnesses, also known as non-communicable diseases (NCDs), are long-lasting medical states that typically advance gradually and endure for prolonged durations, often spanning years or a lifetime without spontaneous resolution. The rising occurrence of chronic conditions represents a significant contributor to the opioids market. A greater number of individuals developing chronic diseases and suffering from persistent pain leads to an escalated need for opioids. While a complex and evolving field in medicine, the application of opioids in managing chronic diseases offers effective pain relief. As an illustration, the National Health Service, a UK government body, reported in June 2024 that 3,615,330 individuals registered with a general practitioner (GP) were identified with non-diabetic hyperglycemia or pre-diabetes (a state of elevated blood sugar insufficient for a diabetes diagnosis) in 2023, representing an 18% rise from 3,065,825 instances in 2022. Consequently, the expanding presence of chronic diseases is fueling the development of the opioids market.

Opioids Market Segmentation: How Does The Market Break Down By Category?

The opioids market covered in this report is segmented –

1) By Product Type: Methadone, Codeine, Fentanyl, Oxycodone, Morphine, Hydrocodone, Other Product Types

2) By Receptor Binding: Strong Agonist, Mild To Moderate Agonist

3) By Basis Of Indication: Inflammatory Condition, Musculoskeletal Pain, Neuropathic Pain, Cancer Pain

4) By Distribution Channel: Hospital, Retail Pharmacies, Online Pharmacies

5) By Application: Pain Management, Cough Treatment, Diarrhea Treatment

Subsegments:

1) By Methadone: Methadone Tablets, Methadone Oral Solution

2) By Codeine: Codeine Phosphate Tablets, Codeine Liquid Formulations

3) By Fentanyl: Fentanyl Patch, Fentanyl Injection, Fentanyl Sublingual Tablets

4) By Oxycodone: Oxycodone Tablets, Oxycodone Extended-Release Formulations

5) By Morphine: Morphine Sulfate Tablets, Morphine Injection, Morphine Extended-Release Capsules

6) By Hydrocodone: Hydrocodone/Acetaminophen Tablets, Hydrocodone Liquid Formulations

7) By Other Product Types: Buprenorphine, Tramadol, Other Combination Products

Opioids Market Trends: What’s Defining The Industry’s Next Phase?

Major companies operating within the opioid market are focused on developing innovative drug solutions to strengthen their competitive position. The introduction of new medications has the potential to effectively treat diseases, enhance healthcare provisions, and expand scientific understanding. For instance, in May 2023, Braeburn Pharmaceuticals Inc., a US-based provider of treatments for opioid addiction, announced that the US Food and Drug Administration had authorized Brixadi (buprenorphine) extended-release injectable for subcutaneous use in the treatment of moderate to severe opioid use disorder (OUD). This product is notable as the first and sole weekly and monthly subcutaneous injection for moderate to severe OUD and the initial buprenorphine injectable to utilize FluidCrystal Injection Depot Technology. Patients currently receiving oral buprenorphine-containing medications are able to transition to equivalent dosages when adhering to the prescribed guidance.

Opioids Market Competitive Overview And Top Companies

Major companies operating in the opioids market are Pfizer Inc., Johnson & Johnson Inc., AbbVie Inc., Sanofi S.A, AstraZeneca Plc, Viatris Inc., Teva Pharmaceutical Industries Limited, Sandoz Inc., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Purdue Pharma L.P., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals plc, Alkermes plc, Lannett Co Inc., Par Pharmaceutical Inc., Mayne Pharma Group Ltd., Cephalon LLC, Insys Therapeutics Inc., Janssen Pharmaceuticals Inc., Rhodes Pharmaceuticals L.P, KVK Tech Inc.

View The Full Opioids Market Report:

https://thebusinessresearchcompany.com/report/opioids-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Opioids Market Top Region By Revenue And Market Share

North America was the largest region in the opioids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the opioids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Opioids Market Size Forecast: How Large Could The Market Become By 2030?

The opioids market has seen consistent expansion in recent times. Its value is projected to reach $23.98 billion in 2025 and then climb to $24.63 billion in 2026, representing a compound annual growth rate (CAGR) of 2.7%. This historical growth was driven by several factors: the frequent occurrence of post-surgical pain, a higher incidence of cancer, extensive opioid prescribing patterns, a shortage of alternative treatments for pain, and a significant reliance on opioids within hospital environments.

The opioids market is projected to experience consistent expansion in the coming years, reaching a value of $28.59 billion by 2030, with a compound annual growth rate (CAGR) of 3.8%. This anticipated growth during the forecast period is driven by factors such as an increasing number of individuals living with chronic pain, the creation of opioid formulations with improved safety profiles, the widening of palliative care services, more defined regulatory frameworks concerning controlled substances, and a heightened need for effective pain relief solutions among older populations. Key developments shaping the industry in the forecast period involve the advancement of precision-based opioid therapies, the incorporation of digital monitoring systems for prescriptions, a transition toward abuse-deterrent product designs, a growing emphasis on long-acting and extended-release opioid options, and a rising utilization of opioids for managing pain associated with cancer.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13021&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Opioids Market Development Factors: Which Trends Are Supporting Demand?

The rising incidence of chronic diseases is anticipated to drive expansion in the opioids market moving forward. Chronic diseases, often referred to as non-communicable diseases (NCDs), are long-term health conditions that typically advance slowly and endure over an extended timeframe. These conditions can last for years or even a lifetime and generally do not resolve spontaneously. The growing frequency of chronic diseases significantly influences the opioids market. As more individuals develop chronic illnesses and suffer from persistent pain, the demand for opioids escalates. The application of opioids in managing chronic diseases represents a complex and evolving field of medicine, offering effective pain relief. For example, in June 2024, data from the National Health Service, a UK government agency, revealed that 3,615,330 people registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition characterized by elevated blood sugar levels not yet reaching diabetes thresholds) in 2023, reflecting an 18% rise from 3,065,825 cases in 2022. Consequently, the increasing prevalence of chronic diseases is fueling growth in the opioids market.

Opioids Market Segment Breakdown: Which Categories Generate The Most Revenue?

The opioids market covered in this report is segmented –

1) By Product Type: Methadone, Codeine, Fentanyl, Oxycodone, Morphine, Hydrocodone, Other Product Types

2) By Receptor Binding: Strong Agonist, Mild To Moderate Agonist

3) By Basis Of Indication: Inflammatory Condition, Musculoskeletal Pain, Neuropathic Pain, Cancer Pain

4) By Distribution Channel: Hospital, Retail Pharmacies, Online Pharmacies

5) By Application: Pain Management, Cough Treatment, Diarrhea Treatment

Subsegments:

1) By Methadone: Methadone Tablets, Methadone Oral Solution

2) By Codeine: Codeine Phosphate Tablets, Codeine Liquid Formulations

3) By Fentanyl: Fentanyl Patch, Fentanyl Injection, Fentanyl Sublingual Tablets

4) By Oxycodone: Oxycodone Tablets, Oxycodone Extended-Release Formulations

5) By Morphine: Morphine Sulfate Tablets, Morphine Injection, Morphine Extended-Release Capsules

6) By Hydrocodone: Hydrocodone/Acetaminophen Tablets, Hydrocodone Liquid Formulations

7) By Other Product Types: Buprenorphine, Tramadol, Other Combination Products

Opioids Market Transformation Trends: Which Innovations Are Driving Change?

Leading players within the opioid sector are concentrating on developing cutting-edge pharmaceutical solutions to strengthen their market standing. The creation of novel drugs has the potential to address illnesses while advancing medical knowledge and healthcare outcomes. As an example, in May 2023, Braeburn Pharmaceuticals Inc., a company based in the United States specializing in treatments for opioid addiction, announced that the US Food and Drug Administration had approved Brixadi (buprenorphine) as an extended-release injectable for subcutaneous administration (under the skin) to manage moderate to severe opioid use disorder (OUD). This product is the first and only weekly and monthly subcutaneous injectable for moderate to severe OUD, as well as the first buprenorphine injectable that employs FluidCrystal Injection Depot Technology. Patients currently using oral buprenorphine-based medications can be switched to corresponding doses when the prescribing guidelines are adhered to.

Opioids Market Key Players And Strategic Industry Positioning

Major companies operating in the opioids market are Pfizer Inc., Johnson & Johnson Inc., AbbVie Inc., Sanofi S.A, AstraZeneca Plc, Viatris Inc., Teva Pharmaceutical Industries Limited, Sandoz Inc., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Purdue Pharma L.P., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals plc, Alkermes plc, Lannett Co Inc., Par Pharmaceutical Inc., Mayne Pharma Group Ltd., Cephalon LLC, Insys Therapeutics Inc., Janssen Pharmaceuticals Inc., Rhodes Pharmaceuticals L.P, KVK Tech Inc.

Access The Complete Opioids Market Report:

https://www.thebusinessresearchcompany.com/report/opioids-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Opioids Market Global Footprint: Which Region Holds Market Leadership?

North America was the largest region in the opioids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the opioids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Is The Market Value Of The Opioids Market Projected To Expand During 2026–2030?

The opioids market has experienced consistent expansion in its size over recent years. Projections indicate it will expand from $23.98 billion in 2025 to $24.63 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 2.7%. Historical market growth factors include the widespread occurrence of post-surgical pain, an increase in cancer cases, common opioid prescribing behaviors, restricted access to other pain relief options, and significant opioid consumption within hospitals.

The opioids market is projected to experience consistent expansion over the coming years. Its value is anticipated to reach $28.59 billion by 2030, driven by a compound annual growth rate (CAGR) of 3.8%. This projected growth during the forecast period stems from factors such as an expanding chronic pain demographic, advancements in developing safer opioid formulations, the broadening of palliative care services, clearer regulatory frameworks for controlled substances, and the escalating need for efficient pain management solutions among an aging populace. Key trends defining this period involve the evolution of precision-guided opioid therapies, the integration of digital prescription monitoring systems, a move towards formulations designed to deter abuse, the wider availability of long-acting and extended-release opioids, and their increasing application in managing oncology-related pain.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13021&type=smp

Which Strategic Drivers Are Supporting The Opioids Market Development?

The rising incidence of chronic diseases is anticipated to drive the expansion of the opioids market in the foreseeable future. Chronic conditions, also referred to as non-communicable diseases (NCDs), are long-lasting health issues that typically progress slowly and persist over an extended duration. These conditions frequently last for years or even a lifetime and generally do not resolve independently. The growing occurrence of chronic diseases is a significant determinant in the opioids market. As more individuals develop chronic conditions and experience persistent pain, there is a heightened demand for opioids. The use of opioids in chronic disease management is an intricate and evolving medical domain, known for its effective pain relief. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition involving elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, marking an 18% increase from 3,065,825 cases in 2022. Consequently, the expanding prevalence of chronic diseases is fueling the growth of the opioids market.

How Are Different Segment Groups Identified Within The Opioids Market?

The opioids market covered in this report is segmented –

1) By Product Type: Methadone, Codeine, Fentanyl, Oxycodone, Morphine, Hydrocodone, Other Product Types

2) By Receptor Binding: Strong Agonist, Mild To Moderate Agonist

3) By Basis Of Indication: Inflammatory Condition, Musculoskeletal Pain, Neuropathic Pain, Cancer Pain

4) By Distribution Channel: Hospital, Retail Pharmacies, Online Pharmacies

5) By Application: Pain Management, Cough Treatment, Diarrhea Treatment

Subsegments:

1) By Methadone: Methadone Tablets, Methadone Oral Solution

2) By Codeine: Codeine Phosphate Tablets, Codeine Liquid Formulations

3) By Fentanyl: Fentanyl Patch, Fentanyl Injection, Fentanyl Sublingual Tablets

4) By Oxycodone: Oxycodone Tablets, Oxycodone Extended-Release Formulations

5) By Morphine: Morphine Sulfate Tablets, Morphine Injection, Morphine Extended-Release Capsules

6) By Hydrocodone: Hydrocodone/Acetaminophen Tablets, Hydrocodone Liquid Formulations

7) By Other Product Types: Buprenorphine, Tramadol, Other Combination Products

Which Trends Are Shaping The Opioids Market Landscape?

Major companies operating in the opioid market are concentrating on developing advanced drug solutions to enhance their competitive standing. The introduction of new medications is vital for treating diseases, improving healthcare, and expanding scientific knowledge. For instance, in May 2023, Braeburn Pharmaceuticals Inc., a US-based firm specializing in treatments for opioid addiction, announced that the US Food and Drug Administration authorized Brixadi (buprenorphine) extended-release injectable for subcutaneous use (beneath the skin) to treat direct to extreme opioid use disorder (OUD). This product is the first and only weekly and monthly subcutaneous infusion available for direct to serious OUD, and it marks the inaugural buprenorphine injectable to incorporate FluidCrystal Injection Depot Technology. Patients currently taking oral buprenorphine-containing medications can transition to equivalent dosages by adhering to the prescribed advice.

Which Companies Are Engaged In The Opioids Market Environment?

Major companies operating in the opioids market are Pfizer Inc., Johnson & Johnson Inc., AbbVie Inc., Sanofi S.A, AstraZeneca Plc, Viatris Inc., Teva Pharmaceutical Industries Limited, Sandoz Inc., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Purdue Pharma L.P., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals plc, Alkermes plc, Lannett Co Inc., Par Pharmaceutical Inc., Mayne Pharma Group Ltd., Cephalon LLC, Insys Therapeutics Inc., Janssen Pharmaceuticals Inc., Rhodes Pharmaceuticals L.P, KVK Tech Inc.

Access The Complete Opioids Market Report:

https://www.thebusinessresearchcompany.com/report/opioids-global-market-report

Which Area Represents The Largest Portion Of The Opioids Market?

North America was the largest region in the opioids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the opioids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Opioids Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=13021&type=smp

Browse Through More Reports Similar to the Global Opioids Market 2026, By The Business Research Company

Opioids Market Report 2026

https://www.thebusinessresearchcompany.com/report/opioids-global-market-report

Morphine Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/morphine-drugs-global-market-report

Opioid Use Disorder Oud Market Report 2026

https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Opioids Market During 2026–2030?

The opioids market size has witnessed steady expansion in recent years. This market is anticipated to expand from $23.98 billion in 2025 to $24.63 billion in 2026, driven by a compound annual growth rate (CAGR) of 2.7%. Historically, this growth can be ascribed to factors like the prevalence of post-surgical pain, a rise in cancer incidence, widespread practices of opioid prescription, the restricted availability of alternative pain therapies, and robust hospital-based opioid usage.

The opioids market size is anticipated to demonstrate consistent growth over the coming years. It is projected to expand to $28.59 billion by 2030, achieving a compound annual growth rate (CAGR) of 3.8%. The increase during this forecast period can be attributed to a growing chronic pain population, the development of safer opioid formulations, an expansion of palliative care services, clearer regulatory guidelines for controlled substances, and a rising demand for effective pain management among aging populations. Significant trends in the forecast period involve the development of precision-guided opioid therapy, the integration of digital prescription monitoring, a shift towards abuse-deterrent formulations, the greater availability of long-acting and extended-release opioids, and an increasing application of opioids in oncology pain management.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13021&type=smp

What Leading Drivers Are Supporting The Opioids Market Expansion?

The rising incidence of chronic diseases is projected to drive the expansion of the opioids market. These enduring medical conditions, also identified as non-communicable diseases (NCDs), are characterized by their gradual progression and prolonged duration, often persisting for many years or even a lifetime without naturally subsiding. The growing frequency of chronic diseases plays a significant role in the opioids market, as the expanding number of individuals experiencing chronic diseases and associated chronic pain leads to a heightened demand for opioids. While complex and continually developing within medicine, the use of opioids in managing chronic diseases effectively alleviates pain. For example, in June 2024, the National Health Service, a UK-based government department, reported that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (defined as elevated blood sugar not high enough for diabetes) in 2023. This marked an 18% increase from 3,065,825 cases in 2022. Consequently, the increasing prevalence of chronic diseases is a primary driver for the growth of the opioids market.

How Is The Opioids Market Categorized Across Its Segment Groups?

The opioids market covered in this report is segmented –

1) By Product Type: Methadone, Codeine, Fentanyl, Oxycodone, Morphine, Hydrocodone, Other Product Types

2) By Receptor Binding: Strong Agonist, Mild To Moderate Agonist

3) By Basis Of Indication: Inflammatory Condition, Musculoskeletal Pain, Neuropathic Pain, Cancer Pain

4) By Distribution Channel: Hospital, Retail Pharmacies, Online Pharmacies

5) By Application: Pain Management, Cough Treatment, Diarrhea Treatment

Subsegments:

1) By Methadone: Methadone Tablets, Methadone Oral Solution

2) By Codeine: Codeine Phosphate Tablets, Codeine Liquid Formulations

3) By Fentanyl: Fentanyl Patch, Fentanyl Injection, Fentanyl Sublingual Tablets

4) By Oxycodone: Oxycodone Tablets, Oxycodone Extended-Release Formulations

5) By Morphine: Morphine Sulfate Tablets, Morphine Injection, Morphine Extended-Release Capsules

6) By Hydrocodone: Hydrocodone/Acetaminophen Tablets, Hydrocodone Liquid Formulations

7) By Other Product Types: Buprenorphine, Tramadol, Other Combination Products

What Trends Are Shaping The Future Of The Opioids Market?

Leading companies in the opioid market are concentrating on developing innovative drug solutions to strengthen their position. The introduction of new medications can address diseases and enhance healthcare along with scientific knowledge. For example, in May 2023, Braeburn Pharmaceuticals Inc., a US-based firm providing treatments for opioid addiction, declared that the US Food and Drug Administration had approved Brixadi (buprenorphine) extended-release injectable for subcutaneous administration (under the skin) for managing moderate to severe opioid use disorder (OUD). This product is the first and only weekly and monthly subcutaneous injection for moderate to severe OUD and the initial buprenorphine injectable to incorporate FluidCrystal Injection Depot Technology. Patients currently on oral buprenorphine-containing medications can be transitioned to equivalent dosages if the prescribed advice is followed.

Which Firms Are Influencing Competition In The Opioids Market?

Major companies operating in the opioids market are Pfizer Inc., Johnson & Johnson Inc., AbbVie Inc., Sanofi S.A, AstraZeneca Plc, Viatris Inc., Teva Pharmaceutical Industries Limited, Sandoz Inc., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Purdue Pharma L.P., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals plc, Alkermes plc, Lannett Co Inc., Par Pharmaceutical Inc., Mayne Pharma Group Ltd., Cephalon LLC, Insys Therapeutics Inc., Janssen Pharmaceuticals Inc., Rhodes Pharmaceuticals L.P, KVK Tech Inc.

Get The Full Opioids Market Report:

https://www.thebusinessresearchcompany.com/report/opioids-global-market-report

Which Region Is The Largest In The Opioids Market?

North America was the largest region in the opioids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the opioids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Opioids Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/opioids-global-market-report

Browse Through More Reports Similar to the Global Opioids Market 2026, By The Business Research Company

Opioids Market Report 2026

https://www.thebusinessresearchcompany.com/report/opioids-global-market-report

Morphine Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/morphine-drugs-global-market-report

Opioid Use Disorder Oud Market Report 2026

https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Opioids Market Over The 2026–2030 Period?

The size of the opioids market has shown consistent expansion over recent years. It is projected to increase from $23.98 billion in 2025 to $24.63 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 2.7%. Key factors driving this historical growth include the prevalence of post-surgical pain, an increase in cancer incidence, common opioid prescription practices, the restricted availability of alternative pain treatments, and significant opioid utilization within hospitals.

The opioids market size is anticipated to experience consistent growth in the upcoming years. It is projected to achieve a valuation of $28.59 billion by 2030, expanding at a compound annual growth rate (CAGR) of 3.8%. The growth during this forecast period can be attributed to an increase in the chronic pain population, the development of safer opioid formulations, the expansion of palliative care services, greater regulatory clarity for controlled substances, and the rising demand for effective pain management among aging populations. Significant trends foreseen in the forecast period include the advancement of precision-guided opioid therapy, the integration of digital prescription monitoring, a shift towards abuse-deterrent formulations, the wider availability of long-acting and extended-release opioids, and their growing utilization in oncology pain management.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13021&type=smp

What Underlying Factors Are Accelerating The Growth Of The Opioids Market?

The future expansion of the opioids market is anticipated to be driven by the rising incidence of chronic diseases. These conditions, also referred to as non-communicable diseases (NCDs), are long-lasting medical issues that typically advance gradually and persist over extended periods, often lasting for years or even a lifetime without self-resolution. The growing number of individuals affected by chronic diseases is a primary contributor to the demand within the opioids market. As more people experience chronic pain associated with these conditions, the need for opioids increases. Opioid application in managing chronic diseases is a intricate and developing field of medicine, known for its effectiveness in alleviating pain. For instance, in June 2024, data from the National Health Service, a UK-based government department, indicated that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition characterized by elevated blood sugar levels, not high enough to be classified as diabetes) in 2023. This represented an 18% surge from 3,065,825 cases recorded in 2022. Consequently, the increasing prevalence of chronic diseases is propelling the growth of the opioids market.

How Is The Opioids Market Segmented Across Key Categories?

The opioids market covered in this report is segmented –

1) By Product Type: Methadone, Codeine, Fentanyl, Oxycodone, Morphine, Hydrocodone, Other Product Types

2) By Receptor Binding: Strong Agonist, Mild To Moderate Agonist

3) By Basis Of Indication: Inflammatory Condition, Musculoskeletal Pain, Neuropathic Pain, Cancer Pain

4) By Distribution Channel: Hospital, Retail Pharmacies, Online Pharmacies

5) By Application: Pain Management, Cough Treatment, Diarrhea Treatment

Subsegments:

1) By Methadone: Methadone Tablets, Methadone Oral Solution

2) By Codeine: Codeine Phosphate Tablets, Codeine Liquid Formulations

3) By Fentanyl: Fentanyl Patch, Fentanyl Injection, Fentanyl Sublingual Tablets

4) By Oxycodone: Oxycodone Tablets, Oxycodone Extended-Release Formulations

5) By Morphine: Morphine Sulfate Tablets, Morphine Injection, Morphine Extended-Release Capsules

6) By Hydrocodone: Hydrocodone/Acetaminophen Tablets, Hydrocodone Liquid Formulations

7) By Other Product Types: Buprenorphine, Tramadol, Other Combination Products

Which Upcoming Trends Are Expected To Influence The Opioids Market?

Major companies operating within the opioid market are dedicated to developing advanced drug solutions to reinforce their position. The discovery of new medications has the capacity to treat diseases, thereby improving healthcare and scientific knowledge. For instance, in May 2023, Braeburn Pharmaceuticals Inc., a US-based provider of treatments for opioid addiction, announced that the US Food and Drug Administration had approved Brixadi (buprenorphine) extended-release injectable for subcutaneous use (beneath the skin) for the treatment of moderate to severe opioid use disorder (OUD). This marks the initial and only weekly and monthly subcutaneous injection for moderate to severe OUD and the first buprenorphine injectable to utilize FluidCrystal Injection Depot Technology. Patients who are currently receiving oral buprenorphine-containing medications can transition to equivalent dosages if the prescribed advice is followed.

Who Are The Dominant Players Shaping The Opioids Market Landscape?

Major companies operating in the opioids market are Pfizer Inc., Johnson & Johnson Inc., AbbVie Inc., Sanofi S.A, AstraZeneca Plc, Viatris Inc., Teva Pharmaceutical Industries Limited, Sandoz Inc., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Purdue Pharma L.P., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals plc, Alkermes plc, Lannett Co Inc., Par Pharmaceutical Inc., Mayne Pharma Group Ltd., Cephalon LLC, Insys Therapeutics Inc., Janssen Pharmaceuticals Inc., Rhodes Pharmaceuticals L.P, KVK Tech Inc.

Read the full opioids market report here:

https://www.thebusinessresearchcompany.com/report/opioids-global-market-report

Which Region Is Projected To Dominate The Opioids Market During The Forecast Period?

North America was the largest region in the opioids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the opioids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Opioids Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13021&type=smp

Browse Through More Reports Similar to the Global Opioids Market 2026, By The Business Research Company

Opioids Market Report 2026

https://www.thebusinessresearchcompany.com/report/opioids-global-market-report

Morphine Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/morphine-drugs-global-market-report

Opioid Use Disorder Oud Market Report 2026

https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the opioids market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Opioids Market between 2026 and 2030?

The opioids market has experienced consistent expansion in its size over recent years. This market is projected to expand from $23.98 billion in 2025 to $24.63 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 2.7%. Historically, this expansion has been driven by factors such as post-surgical pain prevalence, rising cancer incidence, widespread opioid prescription practices, the limited availability of alternative pain therapies, and robust hospital-based opioid usage.

The opioids market is anticipated to experience consistent expansion over the upcoming years. By 2030, its valuation is projected to reach $28.59 billion, demonstrating a compound annual growth rate (CAGR) of 3.8%. This projected increase can be linked to several factors, including an expanding chronic pain demographic, the creation of safer opioid products, the broadening of palliative care provisions, enhanced regulatory clarity regarding controlled substances, and a growing need for effective pain management among older populations. Significant developments expected during this period involve the evolution of precision-guided opioid treatments, the incorporation of digital prescription monitoring, a move towards formulations designed to deter abuse, an increase in the availability of long-acting and extended-release opioids, and their increasing application in managing pain for cancer patients.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13021&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Opioids Market?

The expanding occurrence of chronic illnesses is anticipated to fuel the expansion of the opioids market in the future. Chronic diseases, also recognized as non-communicable diseases (NCDs), are long-duration health issues that usually develop gradually and last for a considerable time. These ailments frequently endure for many years or an entire lifetime and typically do not disappear naturally. The rising incidence of chronic diseases represents a significant contributor to the opioids market. With more individuals developing chronic conditions and suffering from persistent pain, the demand for opioids increases. The application of opioids in managing chronic diseases is an intricate and developing field of medicine, known for its effective pain relief. For example, data from June 2024, sourced from the National Health Service, a UK-based government body, revealed that 3,615,330 individuals registered with a GP received a diagnosis of non-diabetic hyperglycemia or pre-diabetes (a state characterized by elevated blood sugar not reaching diabetic levels) in 2023. This figure indicated an 18% rise from the 3,065,825 cases recorded in 2022. Consequently, the expanding occurrence of chronic diseases is propelling the growth of the opioids market.

How Is The Opioids Market Organized Into Various Segments?

The opioids market covered in this report is segmented –

1) By Product Type: Methadone, Codeine, Fentanyl, Oxycodone, Morphine, Hydrocodone, Other Product Types

2) By Receptor Binding: Strong Agonist, Mild To Moderate Agonist

3) By Basis Of Indication: Inflammatory Condition, Musculoskeletal Pain, Neuropathic Pain, Cancer Pain

4) By Distribution Channel: Hospital, Retail Pharmacies, Online Pharmacies

5) By Application: Pain Management, Cough Treatment, Diarrhea Treatment

Subsegments:

1) By Methadone: Methadone Tablets, Methadone Oral Solution

2) By Codeine: Codeine Phosphate Tablets, Codeine Liquid Formulations

3) By Fentanyl: Fentanyl Patch, Fentanyl Injection, Fentanyl Sublingual Tablets

4) By Oxycodone: Oxycodone Tablets, Oxycodone Extended-Release Formulations

5) By Morphine: Morphine Sulfate Tablets, Morphine Injection, Morphine Extended-Release Capsules

6) By Hydrocodone: Hydrocodone/Acetaminophen Tablets, Hydrocodone Liquid Formulations

7) By Other Product Types: Buprenorphine, Tramadol, Other Combination Products

How Are New Market Trends Shaping The Landscape Of The Opioids Market?

Leading companies operating in the opioid market are concentrating on developing advanced drug therapies to solidify their position. The introduction of new medications can address illnesses, enhance healthcare, and advance scientific understanding. For example, in May 2023, Braeburn Pharmaceuticals Inc., a US-based firm offering solutions for opioid addiction treatment, declared that the US Food and Drug Administration had approved Brixadi (buprenorphine) extended-release injectable for subcutaneous administration (under the skin) for managing moderate to severe opioid use disorder (OUD). This product is the first and only weekly and monthly subcutaneous injection for moderate to severe OUD, and it is also the first buprenorphine injectable to utilize FluidCrystal Injection Depot Technology. Patients currently on oral buprenorphine-containing medications can be transitioned to equivalent dosages, provided the prescription guidelines are followed.

Who Are The Top-Performing Companies In The Opioids Market In Recent Years?

Major companies operating in the opioids market are Pfizer Inc., Johnson & Johnson Inc., AbbVie Inc., Sanofi S.A, AstraZeneca Plc, Viatris Inc., Teva Pharmaceutical Industries Limited, Sandoz Inc., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Purdue Pharma L.P., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals plc, Alkermes plc, Lannett Co Inc., Par Pharmaceutical Inc., Mayne Pharma Group Ltd., Cephalon LLC, Insys Therapeutics Inc., Janssen Pharmaceuticals Inc., Rhodes Pharmaceuticals L.P, KVK Tech Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/opioids-global-market-report

Which Region Currently Holds The Largest Share Of The Opioids Market?

North America was the largest region in the opioids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the opioids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Opioids Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13021&type=smp

Browse Through More Reports Similar to the Global Opioids Market 2026, By The Business Research Company

Opioids Market Report 2026

https://www.thebusinessresearchcompany.com/report/opioids-global-market-report

Morphine Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/morphine-drugs-global-market-report

Opioid Use Disorder Oud Market Report 2026

https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the opioids market from 2025–2034 with trusted insights from The Business Research Company

How Is The Opioids Market Size Expected To Expand Over 2029-2034?

The opioids market has seen modest expansion over recent years. It is anticipated to increase from $23.54 billion in 2024 to $23.98 billion in 2025, achieving a compound annual growth rate (CAGR) of 1.9%. The expansion observed historically is largely due to factors like pain management, surgical procedures, palliative care, and the prevailing regulatory environment.

The opioids market is projected to experience consistent expansion over the coming years. Its valuation is anticipated to reach $27.25 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 3.3%. This projected growth during the forecast period is primarily driven by factors such as non-cancer pain indications, shifts in regulatory frameworks, the rise of telemedicine and remote prescribing practices, and advancements in chronic pain management. Furthermore, significant developments expected in this period encompass opioid-sparing strategies, medication-assisted treatment (mat), enhanced risk mitigation efforts, and various public health initiatives.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13021&type=smp

Which Market Factors Are Fueling The Opioids Industry Growth?

The anticipated increase in surgical procedures is poised to fuel the expansion of the opioids market in the foreseeable future. These procedures are medical interventions where an incision is made using instruments, typically performed in an operating room, and often necessitate anesthesia or respiratory assistance. During surgical operations, opioids serve as pain relievers, anesthesia supplements, or even as primary anesthetic agents. An example provided by the France-based intergovernmental Organization for Economic Co-operation and Development in August 2023 indicates that the total number of cataract surgical procedures carried out in the Czech Republic saw an 8.4% rise, climbing from 131,612 procedures in 2021 to 142,670 procedures in 2022. Additionally, the total volume of laparoscopic repairs for inguinal hernia surgical procedures conducted in Turkey grew by 35.2%, from 18,739 in 2021 to 25,348 in 2022. Consequently, the growing volume of surgical interventions is set to propel the opioids market.

Which Categories Are Covered In The Opioids Market Segmentation Analysis?

The opioids market covered in this report is segmented –

1) By Product Type: Methadone, Codeine, Fentanyl, Oxycodone, Morphine, Hydrocodone, Other Product Types

2) By Receptor Binding: Strong Agonist, Mild To Moderate Agonist

3) By Basis Of Indication: Inflammatory Condition, Musculoskeletal Pain, Neuropathic Pain, Cancer Pain

4) By Distribution Channel: Hospital, Retail Pharmacies, Online Pharmacies

5) By Application: Pain Management, Cough Treatment, Diarrhea Treatment

Subsegments:

1) By Methadone: Methadone Tablets, Methadone Oral Solution

2) By Codeine: Codeine Phosphate Tablets, Codeine Liquid Formulations

3) By Fentanyl: Fentanyl Patch, Fentanyl Injection, Fentanyl Sublingual Tablets

4) By Oxycodone: Oxycodone Tablets, Oxycodone Extended-Release Formulations

5) By Morphine: Morphine Sulfate Tablets, Morphine Injection, Morphine Extended-Release Capsules

6) By Hydrocodone: Hydrocodone/Acetaminophen Tablets, Hydrocodone Liquid Formulations

7) By Other Product Types: Buprenorphine, Tramadol, Other Combination Products

Which Market Trends Are Expected To Define The Future Of The Opioids Market?

Leading companies operating within the opioid market are concentrating on developing advanced drug solutions to bolster their competitive position. The advent of new medications holds the potential to treat diseases and enhance both healthcare practices and scientific knowledge. For instance, in May 2023, Braeburn Pharmaceuticals Inc., a US-based provider of solutions for treating opioid addiction, announced that the US Food and Drug Administration had authorized Brixadi (buprenorphine), an extended-release injectable for subcutaneous use (beneath the skin), for the management of moderate to severe opioid use disorder (OUD). This product stands as the first and sole weekly and monthly subcutaneous injection for moderate to severe OUD, and it is also the first buprenorphine injectable to utilize FluidCrystal Injection Depot Technology. Patients currently receiving oral buprenorphine-containing medications can be transitioned to equivalent dosages, provided that the prescription advice is followed.

Which Organizations Are At The Forefront Of The Opioids Market?

Major companies operating in the opioids market are Pfizer Inc., Johnson & Johnson Inc., AbbVie Inc., Sanofi S.A, AstraZeneca PLC, Viatris Inc., Teva Pharmaceutical Industries Limited, Sandoz Inc., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Purdue Pharma L.P., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals PLC, Alkermes PLC, Lannett Co Inc., Par Pharmaceutical Inc., Mayne Pharma Group Ltd., Cephalon LLC, Insys Therapeutics Inc., Janssen Pharmaceuticals Inc., Rhodes Pharmaceuticals L.P, KVK Tech Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/opioids-global-market-report

Which Geographic Areas Are Driving Strong Demand For The Opioids Market?

North America was the largest region in the opioids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in opioids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=13021&type=smp

Browse Through More Reports Similar to the Global Opioids Market 2025, By The Business Research Company

Generic Pharmaceuticals Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/generic-pharmaceuticals-global-market-report

Pharmacies And Drug Stores Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pharmacies-and-drug-stores-global-market-report

Pharmaceutical Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Opioids Market Size Shifted, And What Is the Outlook Through 2034?

There has been a slight expansion in the size of the opioids market in the past few years. The market is projected to increase from $23.54 billion in 2024 to $23.98 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 1.9%. The previously recorded growth can be linked to applications in pain management, surgical operations, palliative care, and the regulatory landscape.

The market size for opioids is predicted to experience consistent expansion in the upcoming years. With a compound annual growth rate (CAGR) of 3.3%, it is expected to reach $27.25 billion by 2029. The increase during the forecast period is due in part to non-cancer pain indications, modifications in regulations, the rise of telemedicine and remote prescription, and chronic pain management. Projections for the forecast period also highlight major trends such as strategies to reduce opioid usage, medication-assisted treatment (mat), risk reduction, and initiatives surrounding public health.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13021&type=smp

Which Primay Drivers Are Accelerating Growth in the Opioids Market?

The upward trend in surgical procedures is set to boost the opioids market in the future. Surgical procedures, which are essentially medical treatments that necessitate incisions with tools and typically require anesthetic or respiratory assistance, are increasing. Opioids are employed during these procedures for pain management and to either support or serve as the main anesthetic agents. For example, the Organization for Economic Co-operation and Development, an intergovernmental organization based in France, reported an 8.4% increase in the total number of cataract surgical procedures performed in the Czech Republic, up from 131,612 procedures in 2021 to 142,670 procedures in 2022. Moreover, there was a considerable 35.2% increase in the total number of laparoscopic repairs of inguinal hernia surgical procedures in Turkey, from 18,739 in 2021 to 25,348 in 2022. Consequently, the surge in surgical procedures will fuel the growth of the opioid market.

Which Primary Segments of the Opioids Market Are Driving Growth and Industry Transformations?

The opioids market covered in this report is segmented –

1) By Product Type: Methadone, Codeine, Fentanyl, Oxycodone, Morphine, Hydrocodone, Other Product Types

2) By Receptor Binding: Strong Agonist, Mild To Moderate Agonist

3) By Basis Of Indication: Inflammatory Condition, Musculoskeletal Pain, Neuropathic Pain, Cancer Pain

4) By Distribution Channel: Hospital, Retail Pharmacies, Online Pharmacies

5) By Application: Pain Management, Cough Treatment, Diarrhea Treatment

Subsegments:

1) By Methadone: Methadone Tablets, Methadone Oral Solution

2) By Codeine: Codeine Phosphate Tablets, Codeine Liquid Formulations

3) By Fentanyl: Fentanyl Patch, Fentanyl Injection, Fentanyl Sublingual Tablets

4) By Oxycodone: Oxycodone Tablets, Oxycodone Extended-Release Formulations

5) By Morphine: Morphine Sulfate Tablets, Morphine Injection, Morphine Extended-Release Capsules

6) By Hydrocodone: Hydrocodone/Acetaminophen Tablets, Hydrocodone Liquid Formulations

7) By Other Product Types: Buprenorphine, Tramadol, Other Combination Products

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=13021&type=smp

Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Opioids Market?# Market?

North America was the largest region in the opioids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in opioids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Which Technological Trends Are Reshaping the Opioids Industry Dynamics?

Principal companies in the opioid market are channeling their focus on the invention of innovative drug solutions to reinforce their dominance. The development of new pharmaceutical treatments can address various diseases and enhance medical and scientific understandings. For example, in May 2023, Braeburn Pharmaceuticals Inc., a leading American entity providing solutions for opioid addiction treatment, announced that Brixadi (buprenorphine) extended-release injectable for subcutaneous use (under the skin) gained approval from the US Food and Drug Administration. Brixadi represents the first and only weekly and monthly subcutaneous injection targeted for moderate to severe opioid use disorder (OUD). Furthermore, it’s the first buprenorphine injectable formulated with FluidCrystal Injection Depot Technology. If the medical advice is adhered to, patients who are on oral solutions containing buprenorphine can switch over to equivalent doses.

View the full report here:

https://www.thebusinessresearchcompany.com/report/opioids-global-market-report

What Parameters Are Used to Define the Opioids Market?

Opioids refer to a group of powerful medications extracted or manufactured from the opium poppy plant that works on the neurological system to alleviate the effects of pain. They are extremely useful in the treatment of moderate to severe pain, such as post-surgery pain, cancer-related pain, or chronic pain disorders, as well as coughing and diarrhea.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13021

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has the Opioids Market Grown from 2024 to 2025?#_x000D_

In recent times, there has been a consistent escalation in the size of the opioids market. From $23.54 billion in 2024, it is expected to inflate to $24.22 billion by 2025, indicating a compound annual growth rate (CAGR) of 2.9%. This progressive growth during the historical period is credited to factors such as pain management, surgical procedures, palliative care, and the governing regulatory environment._x000D_

_x000D_

#What Growth Rate Is Anticipated for the Opioids Market in the Coming Years?#_x000D_

Predictions anticipate a consistent expansion in the size of the opioids market in the upcoming years. Expectations indicate it will rise to $27.62 billion by 2029, with a 3.3% compound annual growth rate (CAGR). Factors contributing to this growth during the forecasted period include non-cancer related pain symptoms, regulatory modifications, the use of telemedicine and remote prescribing, and the management of chronic pain. Significant developments expected to occur during this period incorporate strategies that reduce opioid usage, medication-assisted treatment (MAT), risk mitigation strategies, and initiatives related to public health._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=13021&type=smp_x000D_

_x000D_

#Who Are the Leading Companies in the Opioids Market?#_x000D_

Major companies operating in the opioids market are Pfizer Inc., Johnson & Johnson Inc., AbbVie Inc., Sanofi S.A, AstraZeneca PLC, Viatris Inc., Teva Pharmaceutical Industries Limited, Sandoz Inc., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Purdue Pharma L.P., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals PLC, Alkermes PLC, Lannett Co Inc., Par Pharmaceutical Inc., Mayne Pharma Group Ltd., Cephalon LLC, Insys Therapeutics Inc., Janssen Pharmaceuticals Inc., Rhodes Pharmaceuticals L.P, KVK Tech Inc._x000D_

_x000D_

#What Are the Key Drivers of the Opioids Market?#_x000D_

The anticipated surge in surgical procedures is set to fuel the opioids market’s expansion. Surgical procedures, described as medical treatments that necessitate the use of surgical instruments to make an incision, are typically carried out in an operating room and often require anesthesia or respiratory assistance. Opioids are used in these settings to manage pain and serve as supporting or primary anesthetic agents. For example, according to the France-based intergovernmental organization, the Organization for Economic Co-operation and Development, in August 2023, cataract surgeries increased by 8.4% from 131,612 procedures in 2021 to 142,670 procedures in 2022 in the Czech Republic. Additionally, in Turkey, laparoscopic repairs of inguinal hernia rose by 35.2% from 18,739 procedures in 2021 to 25,348 procedures in 2022. Consequently, the escalating number of surgical procedures will stimulate the opioids market.

Opioids Market Driver: Growth in Chronic Diseases Prevalence to Fuel Opioids Market Expansion

_x000D_

 

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=13021&type=smp_x000D_

_x000D_

#What Are the Key Market Segments in the Opioids Industry?#_x000D_

The opioids market covered in this report is segmented –_x000D_

_x000D_

1) By Product Type: Methadone, Codeine, Fentanyl, Oxycodone, Morphine, Hydrocodone, Other Product Types_x000D_

2) By Receptor Binding: Strong Agonist, Mild To Moderate Agonist_x000D_

3) By Basis Of Indication: Inflammatory Condition, Musculoskeletal Pain, Neuropathic Pain, Cancer Pain_x000D_

4) By Distribution Channel: Hospital, Retail Pharmacies, Online Pharmacies_x000D_

5) By Application: Pain Management, Cough Treatment, Diarrhea Treatment_x000D_

_x000D_

Subsegments:_x000D_

1) By Methadone: Methadone Tablets, Methadone Oral Solution_x000D_

2) By Codeine: Codeine Phosphate Tablets, Codeine Liquid Formulations_x000D_

3) By Fentanyl: Fentanyl Patch, Fentanyl Injection, Fentanyl Sublingual Tablets_x000D_

4) By Oxycodone: Oxycodone Tablets, Oxycodone Extended-Release Formulations_x000D_

5) By Morphine: Morphine Sulfate Tablets, Morphine Injection, Morphine Extended-Release Capsules_x000D_

6) By Hydrocodone: Hydrocodone/Acetaminophen Tablets, Hydrocodone Liquid Formulations_x000D_

7) By Other Product Types: Buprenorphine, Tramadol, Other Combination Products_x000D_

_x000D_

#What Are the Latest Trends in the Opioids Market?#_x000D_

Leading corporations in the opioid market are striving to innovate superior drug solutions to bolster their standing. The development of new pharmaceuticals can aid in the treatment of diseases and the enhancement of health care and scientific understanding. For example, in May 2023, Braeburn Pharmaceuticals Inc., a company based in the United States that offers solutions for opioid addiction management, announced that the US Food and Drug Administration has approved Brixadi (buprenorphine) as an extended-release injectable for subcutaneous use (under the skin) to manage moderate to severe opioid use disorder (OUD). This is the first and only weekly and monthly subcutaneous injection for moderate to severe OUD, and the first buprenorphine injectable that uses FluidCrystal Injection Depot Technology. Thus, patients who have been prescribed oral buprenorphine can switch to equivalent doses if they adhere to the prescription guidelines._x000D_

_x000D_

#Access The Full Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/opioids-global-market-report_x000D_

_x000D_

#What Are the Key Regional Markets in the Opioids Industry?#_x000D_

North America was the largest region in the opioids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in opioids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa._x000D_

_x000D_

#Purchase The Full Report Today:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13021_x000D_

_x000D_

#This Report Delivers Insight On: #_x000D_

1. How big is the opioids market, and how is it changing globally?_x000D_

2. Who are the major companies in the opioids market, and how are they performing?_x000D_

3. What are the key opportunities and risks in the opioids market right now?_x000D_

4. Which products or customer segments are growing the most in the opioids market?_x000D_

5. What factors are helping or slowing down the growth of the opioids market?_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 2071930708_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model